Our daily board moves wrap includes Beverley Nichols, Mark Turner, Marcel Bonn-Miller, Bruce Linton, David Pryce, and Aida Tabakovic.
AusCann Group Holdings has appointed cannabinoid expert and medical executive Dr Marcel Bonn-Miller as non-executive director. Dr Bonn-Miller is the global clinical scientific director of Spectrum Therapeutics, the medical division of Canopy Growth Corporation which is the largest shareholder of AusCann. He replaces Bruce Linton as nominee director from Canopy. David Pryce, alternate director for Mr Linton, has also resigned.
Aida Tabakovic has been appointed joint company secretary of Indiana Resources. Ms Tabakovic has over 11 years of experience and was involved in listing a number of junior exploration companies on the ASX.